Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis

Acta Psychiatr Scand. 2009 Jan;119(1):71-7. doi: 10.1111/j.1600-0447.2008.01253.x. Epub 2008 Aug 29.

Abstract

Objective: The study aimed to establish clinical predictors of non-affective acute remitting psychosis (NARP) and assess whether these patients showed a distinct serotonergic profile.

Method: First-episode never treated psychotic patients diagnosed of paranoid schizophrenia (n=35; 21 men and 14 women) or NARP (n=28; 15 men and 13 women) were included.

Results: NARP patients showed significantly lower negative symptomatology, better premorbid adjustment, shorter duration of untreated psychosis, more depressive symptomatology and a lower number of 5-HT2A receptors than the paranoid schizophrenia patients. In the logistic regression, the four variables associated with the presence of NARP were: low number of 5-HT2A receptors; good premorbid adjustment; low score in the item 'hallucinatory behaviour' and reduced duration of untreated psychosis.

Conclusion: Our findings support the view that NARP is a highly distinctive condition different from either affective psychosis or other non-affective psychosis such as schizophrenia, and highlight the need for its validation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Biomarkers / blood
  • Blood Platelets / metabolism
  • Diagnosis, Differential
  • Female
  • Humans
  • Male
  • Predictive Value of Tests
  • Psychiatric Status Rating Scales
  • Psychotic Disorders / blood*
  • Psychotic Disorders / classification
  • Psychotic Disorders / diagnosis*
  • Receptor, Serotonin, 5-HT2A / blood*
  • Remission, Spontaneous
  • Schizophrenia, Paranoid / blood
  • Schizophrenia, Paranoid / classification
  • Schizophrenia, Paranoid / diagnosis
  • Serotonin / blood*
  • Spain
  • Young Adult

Substances

  • Biomarkers
  • Receptor, Serotonin, 5-HT2A
  • Serotonin